This list is an analysis based on recent market events. It's not an investment recommendation.
About
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Innovative Properties stocks are traded under the ticker 7IP.MU.
When is the next Innovative Properties earnings date?▼
Innovative Properties is going to release the next earnings report on March 11, 2027.
What were Innovative Properties earnings last quarter?▼
7IP.MU earnings for the last quarter are 0.02 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Innovative Properties revenue for the last year?▼
Innovative Properties revenue for the last year amounts to 554.46M EUR.
What is Innovative Properties net income for the last year?▼
7IP.MU net income for the last year is 79.02M EUR.
In which sector is Innovative Properties located?▼
Innovative Properties operates in the Other sector.
When did Innovative Properties complete a stock split?▼
Innovative Properties has not had any recent stock splits.